Objective:To explore the impact of adolescent mental health status on smartphone addiction, and construct a predictive model for smartphone addiction based on the eXtreme Gradient Boosting(XGBoost) algorithm and multivariate Logistic regression.Methods:In April 2023, a cross-sectional survey was conducted among 14 666 adolescents.All participants were systematically evaluated using a self-developed general information questionnaire, the middle school student mental health scale(MSSMHS), the adolescents self-harm scale(ASHS), the interaction anxiousness scale(IAS), the mobile phone addiction index(MPAI), the middle school students shame scale(MSSS), the UCLA loneliness scale(UCLA-LS), the multidimensional peer victimization scale(MPVS), and the basic psychological needs scale(BPNS).R software version 4.3.2 was used for data analysis. Participants were randomly divided into training set and validation set at the ratio of 7∶3.The XGBoost model and multivariate logistic regression model were constructed to predict the risk of smartphone addiction, and a nomogram was plotted.Model performance was evaluated using the Hosmer-Lemeshow test, area under the curve(AUC), and accuracy(ACC).Results:(1) A total of 14 036 high school students were included in the study, with 5 069(36.1%) exhibited smartphone addiction.The training set comprised 9 826 students, with 3 549(36.1%) being smartphone addicts.The validation set included 4 210 students, with 1 520(36.1%) being smartphone addicts.(2) The XGBoost model identified shame-proneness and social anxiety as the two main predictors of smartphone addiction.(3) Multivariate Logistic regression analysis revealed that anxiety( B=0.328, OR(95% CI)=1.39(1.07-1.81), P=0.015), interpersonal sensitivity( B=0.311, OR(95% CI)=1.36(1.05-1.77), P=0.018), learning pressure( B=0.606, OR(95% CI)=1.83(1.46-2.31), P<0.001), mood swings( B=0.775, OR(95% CI)=2.17(1.70-2.78), P<0.001), social anxiety( B=0.024, OR(95% CI)=1.02(1.01-1.04), P<0.001), shame-proneness( B=0.049, OR(95% CI)=1.05(1.04-1.06), P<0.001), and peer victimization( B=0.037, OR(95% CI)=1.04(1.02-1.06), P<0.001) were significant predictors of smartphone addiction.(4) The ACC and AUC values of the XGBoost model were 0.890 and 0.929 in the training set, and 0.865 and 0.864 in the validation set, respectively.The multivariate Logistic regression model achieved ACC and AUC values of 0.870 and 0.854 in the training set, and 0.867 and 0.859 in the validation set, respectively. Conclusion:Anxiety, interpersonal sensitivity, learning pressure, mood swings, social anxiety, shame-proneness, and peer victimization are identified risk predictors of smartphone addiction in high school adolescents.

Objective:To evaluate the validity and reliability of the Simplified Chinese version of the Beck Cognitive Insight Scale(SC-BCIS).Methods:Totally 188 patients with schizophrenia meeting the Diagnostic and Statistical Manual of Mental Disorders,Fifth Edition(DSM-5)diagnostic criteria were selected for SC-BCIS and the Insight and Treatment Attitudes Questionnaire(ITAQ)assessment.Thirty-eight patients were selected for retest-ing within 4 weeks.The item analysis was conducted using the Spearman correlation method,and the reliability of the scale was tested with Cronbach's α coefficient and ICC coefficient.The structural validity of the scale was ex-amined through principal component analysis and exploratory factor analysis.Results:The correlation coefficients between the 15 item scores and the total score of the SC-BCIS all met the screening criteria.The Cronbach's α coef-ficient of the scale was 0.69,the test-retest ICC value was 0.82,the ICC coefficient between the SC-BCIS and ITAQ scales was 0.83,and the scale had a two-factor structure,with a cumulative contribution rate of 42.4％for the two factors.Conclusion:The Simplified Chinese version of the Beck Cognitive Insight Scale(SC-BCIS)has good validity and reliability in measuring cognitive insight in patients with schizophrenia.

Objective:To explore the impact of adolescent mental health status on smartphone addiction, and construct a predictive model for smartphone addiction based on the eXtreme Gradient Boosting(XGBoost) algorithm and multivariate Logistic regression.Methods:In April 2023, a cross-sectional survey was conducted among 14 666 adolescents.All participants were systematically evaluated using a self-developed general information questionnaire, the middle school student mental health scale(MSSMHS), the adolescents self-harm scale(ASHS), the interaction anxiousness scale(IAS), the mobile phone addiction index(MPAI), the middle school students shame scale(MSSS), the UCLA loneliness scale(UCLA-LS), the multidimensional peer victimization scale(MPVS), and the basic psychological needs scale(BPNS).R software version 4.3.2 was used for data analysis. Participants were randomly divided into training set and validation set at the ratio of 7∶3.The XGBoost model and multivariate logistic regression model were constructed to predict the risk of smartphone addiction, and a nomogram was plotted.Model performance was evaluated using the Hosmer-Lemeshow test, area under the curve(AUC), and accuracy(ACC).Results:(1) A total of 14 036 high school students were included in the study, with 5 069(36.1%) exhibited smartphone addiction.The training set comprised 9 826 students, with 3 549(36.1%) being smartphone addicts.The validation set included 4 210 students, with 1 520(36.1%) being smartphone addicts.(2) The XGBoost model identified shame-proneness and social anxiety as the two main predictors of smartphone addiction.(3) Multivariate Logistic regression analysis revealed that anxiety( B=0.328, OR(95% CI)=1.39(1.07-1.81), P=0.015), interpersonal sensitivity( B=0.311, OR(95% CI)=1.36(1.05-1.77), P=0.018), learning pressure( B=0.606, OR(95% CI)=1.83(1.46-2.31), P<0.001), mood swings( B=0.775, OR(95% CI)=2.17(1.70-2.78), P<0.001), social anxiety( B=0.024, OR(95% CI)=1.02(1.01-1.04), P<0.001), shame-proneness( B=0.049, OR(95% CI)=1.05(1.04-1.06), P<0.001), and peer victimization( B=0.037, OR(95% CI)=1.04(1.02-1.06), P<0.001) were significant predictors of smartphone addiction.(4) The ACC and AUC values of the XGBoost model were 0.890 and 0.929 in the training set, and 0.865 and 0.864 in the validation set, respectively.The multivariate Logistic regression model achieved ACC and AUC values of 0.870 and 0.854 in the training set, and 0.867 and 0.859 in the validation set, respectively. Conclusion:Anxiety, interpersonal sensitivity, learning pressure, mood swings, social anxiety, shame-proneness, and peer victimization are identified risk predictors of smartphone addiction in high school adolescents.

Objective:To observe the changes of central visual acuity and extracentral visual acuity in eyes with non-arteritic central retinal artery occlusion (NA-CRAO).Methods:A retrospective clinical study. From January 1, 2017 to December 31, 2024, 140 patients (140 eyes) diagnosed with NA-CRAO through ophthalmic examination at Department of Ophthalmology of First People's Hospital of Xianyang City were included in the study. All affected eyes underwent best corrected visual acuity (BCVA), visual field, intraocular pressure, fundus color photography, optical coherence tomography (OCT), and fluorescein angiography (FFA) examinations. After a clear diagnosis, conservative treatment such as reducing intraocular pressure, relieving spasms, and dilating blood vessels should be given immediately. Simultaneously, intravenous and/or arterial thrombolysis therapy should be administered based on the patient's overall condition. Under the same treatment conditions as other treatments, 33 eyes were treated with hyperbaric oxygen therapy within 24 hours after seeking medical attention. The changes in central visual acuity (BCVA) and peripheral visual acuity of the affected eye one month after treatment were observed. BCVA improvement of ≥ 1 line was defined as the increase of no light sensitivity to light sensitivity or above, and the increase of light sensitivity to 0.01 or above. The visual acuity outside the center was determined by the 0 ° axis in front of the eyeball at eye level, and was 10 ° outside visual acuity on the temporal side. Multivariate analysis using logistic regression analysis.Results:Among the 140 cases (140 eyes), there were 84 males (84 eyes) and 56 females (56 eyes). The mean age was (63.89±10.78) years. The duration of illness from the onset of symptoms to the time of diagnosis was 48 (2-720) hours. 6, 1, 14, 47, 41, 16, and 15 eyes were diagnosed with BCVA without light perception, uncertain light perception, manual/anterior, digital/anterior, 0.01-0.10, and ≥ 0.10, respectively. FFA examination revealed delayed arm retinal circulation time and filling of the retinal artery trunk to the peak, with changes in the "arterial front" observed in 126 eyes. OCT examination showed extensive edema and unclear structure in the inner layer of the retina in all patients. Out of 140 eyes, 122 were treated with intravenous thrombolysis and 4 with arterial thrombolysis; 14 eyes did not receive thrombolytic therapy. After treatment, 38 eyes (27.1 %) showed an improvement of BCVA ≥ 1; 67 eyes (47.9%) did not show an improvement in BCVA, and the affected eye had a BCVA of approximately 0.6 without light perception; 17 eyes (12.1 %) showed improvement in peripheral vision, and the peripheral vision of the affected eyes ranged from 0.01 to 0.1, all of whom were patients undergoing intravenous thrombolysis, and prior to treatment, this group of patients had complete blindness in the coarse side visual field of the Amsler grid, and their out of center visual acuity could not be measured. Among the 33 eyes treated with hyperbaric oxygen therapy, 24 eyes (72.7%) showed an increase in BCVA after treatment; 9 eyes did not improve, among which 4 eyes (12.1%) showed improvement in out of center visual acuity. Among the 107 eyes that did not receive hyperbaric oxygen therapy, 49 eyes (45.8%) showed an increase in BCVA after treatment. There was no improvement in 58 eyes (54.2%), among which 13 eyes (12.1%) showed an improvement in out of center visual acuity. The results of logistic regression analysis showed that intravenous thrombolysis and hyperbaric oxygen therapy were independent predictive factors for the improvement of central and extra central visual acuity ( P<0.05). Conclusions:Hyperbaric oxygen therapy within 24 hours of seeking medical attention for patients with NA-CRAO disease course ≤ 1 month has a significant effect on the recovery of central and extra central vision. Intravenous thrombolysis and hyperbaric oxygen therapy are independent predictive factors for the improvement of central and extra central vision.

Objective:To evaluate the validity and reliability of the Simplified Chinese version of the Beck Cognitive Insight Scale(SC-BCIS).Methods:Totally 188 patients with schizophrenia meeting the Diagnostic and Statistical Manual of Mental Disorders,Fifth Edition(DSM-5)diagnostic criteria were selected for SC-BCIS and the Insight and Treatment Attitudes Questionnaire(ITAQ)assessment.Thirty-eight patients were selected for retest-ing within 4 weeks.The item analysis was conducted using the Spearman correlation method,and the reliability of the scale was tested with Cronbach's α coefficient and ICC coefficient.The structural validity of the scale was ex-amined through principal component analysis and exploratory factor analysis.Results:The correlation coefficients between the 15 item scores and the total score of the SC-BCIS all met the screening criteria.The Cronbach's α coef-ficient of the scale was 0.69,the test-retest ICC value was 0.82,the ICC coefficient between the SC-BCIS and ITAQ scales was 0.83,and the scale had a two-factor structure,with a cumulative contribution rate of 42.4％for the two factors.Conclusion:The Simplified Chinese version of the Beck Cognitive Insight Scale(SC-BCIS)has good validity and reliability in measuring cognitive insight in patients with schizophrenia.

Objective:To observe the changes of central visual acuity and extracentral visual acuity in eyes with non-arteritic central retinal artery occlusion (NA-CRAO).Methods:A retrospective clinical study. From January 1, 2017 to December 31, 2024, 140 patients (140 eyes) diagnosed with NA-CRAO through ophthalmic examination at Department of Ophthalmology of First People's Hospital of Xianyang City were included in the study. All affected eyes underwent best corrected visual acuity (BCVA), visual field, intraocular pressure, fundus color photography, optical coherence tomography (OCT), and fluorescein angiography (FFA) examinations. After a clear diagnosis, conservative treatment such as reducing intraocular pressure, relieving spasms, and dilating blood vessels should be given immediately. Simultaneously, intravenous and/or arterial thrombolysis therapy should be administered based on the patient's overall condition. Under the same treatment conditions as other treatments, 33 eyes were treated with hyperbaric oxygen therapy within 24 hours after seeking medical attention. The changes in central visual acuity (BCVA) and peripheral visual acuity of the affected eye one month after treatment were observed. BCVA improvement of ≥ 1 line was defined as the increase of no light sensitivity to light sensitivity or above, and the increase of light sensitivity to 0.01 or above. The visual acuity outside the center was determined by the 0 ° axis in front of the eyeball at eye level, and was 10 ° outside visual acuity on the temporal side. Multivariate analysis using logistic regression analysis.Results:Among the 140 cases (140 eyes), there were 84 males (84 eyes) and 56 females (56 eyes). The mean age was (63.89±10.78) years. The duration of illness from the onset of symptoms to the time of diagnosis was 48 (2-720) hours. 6, 1, 14, 47, 41, 16, and 15 eyes were diagnosed with BCVA without light perception, uncertain light perception, manual/anterior, digital/anterior, 0.01-0.10, and ≥ 0.10, respectively. FFA examination revealed delayed arm retinal circulation time and filling of the retinal artery trunk to the peak, with changes in the "arterial front" observed in 126 eyes. OCT examination showed extensive edema and unclear structure in the inner layer of the retina in all patients. Out of 140 eyes, 122 were treated with intravenous thrombolysis and 4 with arterial thrombolysis; 14 eyes did not receive thrombolytic therapy. After treatment, 38 eyes (27.1 %) showed an improvement of BCVA ≥ 1; 67 eyes (47.9%) did not show an improvement in BCVA, and the affected eye had a BCVA of approximately 0.6 without light perception; 17 eyes (12.1 %) showed improvement in peripheral vision, and the peripheral vision of the affected eyes ranged from 0.01 to 0.1, all of whom were patients undergoing intravenous thrombolysis, and prior to treatment, this group of patients had complete blindness in the coarse side visual field of the Amsler grid, and their out of center visual acuity could not be measured. Among the 33 eyes treated with hyperbaric oxygen therapy, 24 eyes (72.7%) showed an increase in BCVA after treatment; 9 eyes did not improve, among which 4 eyes (12.1%) showed improvement in out of center visual acuity. Among the 107 eyes that did not receive hyperbaric oxygen therapy, 49 eyes (45.8%) showed an increase in BCVA after treatment. There was no improvement in 58 eyes (54.2%), among which 13 eyes (12.1%) showed an improvement in out of center visual acuity. The results of logistic regression analysis showed that intravenous thrombolysis and hyperbaric oxygen therapy were independent predictive factors for the improvement of central and extra central visual acuity ( P<0.05). Conclusions:Hyperbaric oxygen therapy within 24 hours of seeking medical attention for patients with NA-CRAO disease course ≤ 1 month has a significant effect on the recovery of central and extra central vision. Intravenous thrombolysis and hyperbaric oxygen therapy are independent predictive factors for the improvement of central and extra central vision.

Objective:To systematically evaluate the relationship between maternal arsenic exposure and neonatal mortality (NM) and infant mortality (IM).Methods:Literature searches were conducted through PubMed, Web of Science, Embase, Cochrane Library, CNKI database, Wanfang Data Knowledge Service Platform, VIP Chinese Journal Service Platform, and the Chinese Biomedical Literature Database to include case-control, cohort, and cross-sectional studies on the relationship between maternal arsenic exposure and NM, IM published domestically and internationally. The search period was from database establishment to June 4, 2023. Data analysis was conducted using Stata MP 16.0 software, and heterogeneity tests were performed using I2 statistics and Q-test. Fixed effect model (no significant heterogeneity, I2≤50%, P≥0.100) or random effect model (significant heterogeneity, I2 > 50%, P < 0.100) was selected according to heterogeneity among study results for meta-analysis. The OR value (95% CI) was used as the effect value, and subgroup analysis was performed based on different exposure index, arsenic exposure levels in drinking water and study types. At the same time, the dose-response relationship between maternal arsenic exposure and NM, IM was analyzed using generalized least square method. Results:Finally, 9 English literature articles (including 3 053 women and 74 172 maternal and infant pairs) were included, including 6 articles on NM outcomes and 8 articles on IM outcomes. After heterogeneity testing, there was significant heterogeneity in NM ( I2 = 75.20%, P = 0.001) and IM ( I2 = 62.50%, P = 0.009) among all studies. Random effect model was used for meta-analysis, and the combined OR values (95% CI) of NM and IM were 1.38 (1.11 - 1.73) and 1.51 (1.21 - 1.89), respectively. According to the exposure index grouping, in the NM outcome, all studies used drinking water arsenic as the exposure index, and the combined OR value (95% CI) of drinking water arsenic was 1.38 (1.11 - 1.73). In the IM outcome, the combined OR values (95% CI) for urinary arsenic and drinking water arsenic were 3.42 (1.38 - 8.47) and 1.44 (1.16 - 1.79), respectively. According to the grouping of arsenic exposure levels in drinking water, the combined OR values (95% CI) for high and low exposure levels ( > 50 and > 10 - 50 μg/L) in NM and IM outcomes were 1.18 (0.97 - 1.44), 1.54 (1.41 - 1.67), and 1.22 (1.03 - 1.43), 1.55 (1.18 - 2.03), respectively. According to the study types grouping, the combined OR values (95% CI) for retrospective, prospective, and cross-sectional studies in NM and IM outcomes were 1.54 (1.41 - 1.67), 1.11 (0.96 - 1.28), 1.90 (1.01 - 3.55), and 1.55 (1.18 - 2.03), 2.01 (0.82 - 4.94), 1.58 (0.87 - 2.88), respectively. The dose-response relationship analysis showed that the dose-response relationship between maternal arsenic exposure and IM exhibited a non-linear trend (χ 2 = 5.75, P = 0.017). Conclusion:Maternal arsenic exposure is correlated with NM and IM, and there is a non-linear dose-response relationship with IM.

Objective:To systematically evaluate the relationship between maternal arsenic exposure and neonatal mortality (NM) and infant mortality (IM).Methods:Literature searches were conducted through PubMed, Web of Science, Embase, Cochrane Library, CNKI database, Wanfang Data Knowledge Service Platform, VIP Chinese Journal Service Platform, and the Chinese Biomedical Literature Database to include case-control, cohort, and cross-sectional studies on the relationship between maternal arsenic exposure and NM, IM published domestically and internationally. The search period was from database establishment to June 4, 2023. Data analysis was conducted using Stata MP 16.0 software, and heterogeneity tests were performed using I2 statistics and Q-test. Fixed effect model (no significant heterogeneity, I2≤50%, P≥0.100) or random effect model (significant heterogeneity, I2 > 50%, P < 0.100) was selected according to heterogeneity among study results for meta-analysis. The OR value (95% CI) was used as the effect value, and subgroup analysis was performed based on different exposure index, arsenic exposure levels in drinking water and study types. At the same time, the dose-response relationship between maternal arsenic exposure and NM, IM was analyzed using generalized least square method. Results:Finally, 9 English literature articles (including 3 053 women and 74 172 maternal and infant pairs) were included, including 6 articles on NM outcomes and 8 articles on IM outcomes. After heterogeneity testing, there was significant heterogeneity in NM ( I2 = 75.20%, P = 0.001) and IM ( I2 = 62.50%, P = 0.009) among all studies. Random effect model was used for meta-analysis, and the combined OR values (95% CI) of NM and IM were 1.38 (1.11 - 1.73) and 1.51 (1.21 - 1.89), respectively. According to the exposure index grouping, in the NM outcome, all studies used drinking water arsenic as the exposure index, and the combined OR value (95% CI) of drinking water arsenic was 1.38 (1.11 - 1.73). In the IM outcome, the combined OR values (95% CI) for urinary arsenic and drinking water arsenic were 3.42 (1.38 - 8.47) and 1.44 (1.16 - 1.79), respectively. According to the grouping of arsenic exposure levels in drinking water, the combined OR values (95% CI) for high and low exposure levels ( > 50 and > 10 - 50 μg/L) in NM and IM outcomes were 1.18 (0.97 - 1.44), 1.54 (1.41 - 1.67), and 1.22 (1.03 - 1.43), 1.55 (1.18 - 2.03), respectively. According to the study types grouping, the combined OR values (95% CI) for retrospective, prospective, and cross-sectional studies in NM and IM outcomes were 1.54 (1.41 - 1.67), 1.11 (0.96 - 1.28), 1.90 (1.01 - 3.55), and 1.55 (1.18 - 2.03), 2.01 (0.82 - 4.94), 1.58 (0.87 - 2.88), respectively. The dose-response relationship analysis showed that the dose-response relationship between maternal arsenic exposure and IM exhibited a non-linear trend (χ 2 = 5.75, P = 0.017). Conclusion:Maternal arsenic exposure is correlated with NM and IM, and there is a non-linear dose-response relationship with IM.

Objective:To construct a recombinant bioluminescent bacteriophage (HT7) targeting Escherichia coli, and evaluate its ability to identify Escherichia coli. Methods:Initially, pCRISPR-sg (1-10) and PFN-1000 plasmid strains were constructed by genetic engineering, and the most efficient small guild RNA (sgRNA) were screened by bilayer plate. By the gene editing technique, which comprised homologous recombination and clustered regularly interspaced short palin dromic repeats (CRISPR)-Cas system, the Nanoluc luciferase gene was integrated into the downstream non-coding region of 10A gene of T7 phage, to constructe the bioluminescent phage HT7 successfully. The difference of biological characteristics between HT7 phage and T7 phage was evaluated by plaque assay and liquid amplification assay. In addition, 51 strains of Escherichia coli, 20 strains of Klebsiella pneumoniae, 14 strains of Staphylococcus aureus, 6 strains of Enterococcus faecium, 5 strains of Enterococcus faecalis, 3 strains of Acinetobacter baumannii and 1 strain of Pseudomonas aeruginosa were collected and isolated to evaluate the limit of detection and specificity of HT7 phage. Results:Among the 10 CRISPR-targeted cleavage systems constructed, sgRNA8 exhibited the highest cleavage efficiency, with a cleavage rate of 0.18. After three rounds of recombination screening using the pCas9/pCRISPR/PFN-1000 triple-plasmid system, PCR validation yielded recombinant phage bands at 2 798 bp, indicating the successful construction of the HT7 phage. The recombinant phage showed significant differences in biological characteristics in terms of lysis efficiency ( P<0.001), one-step growth curve ( P=0.001), and infection multiplicity ( P=0.031). Both lysis burst time and log growth node were extended by 10 min, with the optimal infection multiplicity being 0.1. Clinical sample testing identified lysis of 6 strains of Escherichia coli within 4.5 h, while other strains remained unaffected, with detection of pathogenic bacteria below 10 CFU/ml. Conclusions:The developed pCas9/pCRISPR/PFN-1000 triple-plasmid editing system efficiently edits the bacteriophage genome. The constructed HT7 fluorescent bacteriophage enables the detection of Escherichia coli below 10 CFU/ml within 4.5 hours, demonstrating low detection limits and high detection specificity.

Objective To investigate the effect of growth hormone(GH)pretreatment on the improvement of eu-ploid and pregnancy outcome.Methods A prospective analysis was conducted on 134 patients undergoing preim-plantation genetic testing for aneuploidy(PGT-A),among whom 30 patients were self-controlled and 104 patients were inter-group controlled.According to whether GH was added,the patients were divided into GH pretreatment group and GH non-pretreatment group.GH pretreatment included subcutaneous injection of GH 2U/day for 4-6 weeks before the start of gonadotropin(Gn),and the dose was doubled on the day of Gn until the trigger day.GH non-pretreatment meant no GH treatment,GH pretreatment was given when the previous PGT-A cycle failed within one year when the PGT-A was performed again,forming the self-control group.The basic situation,blastocyst situa-tion and pregnancy outcome were compared between the groups by inter-group and self-control.Results No matter in the group control or self-controlled group,the endometrial thickness on the day of HCG,ovarian sensitivity index(OSI),number of oocytes obtained,MII oocytes,2PN number,2PN fertilization rate,available oocyte rate,num-ber of biopsy blastocysts,number of euploid blastocysts,euploid blastocyst rate,and at least one euploid rate sig-nificantly increased after GH pretreatment,with statistically significant differences(P＜0.05).The total amount of Gn,Gn days,number of mosaic blastocysts,and mosaic blastocyst rate were not significantly changed after GH pretreatment,with no statistically significant differences.The implantation rate and clinical pregnancy rate in-creased after GH pretreatment,but with no statistically significant differences.Conclusion GH pretreatment can significantly improve the number and rate of euploid embryos in patients undergoing PGT-A,and has a tendency to improve pregnancy outcome.